Showing results (181-190 of 6,006) with videos related to
Sort By:
Pageof 601
Molecular Cancer Therapeutics|January 20, 2005
Up-regulation of c-Jun-NH2-kinase pathway contributes to the induction of mitochondria-mediated apoptosis by alpha-tocopheryl succinate in human prostate cancer cellsKe Zu, Lesleyann Hawthorn, Clement IpMolecular Cancer Therapeutics|January 7, 2004
Induction of CYP1A1 in tumor cells by the antitumor agent 2-[4-amino-3-methylphenyl]-5-fluoro-benzothiazole: a potential surrogate marker for patient sensitivityCurtis D Hose, Melinda Hollingshead, Edward A Sausville, et al.Molecular Cancer Therapeutics|January 7, 2004
Nitric oxide does not mediate but inhibits transformation and tumor phenotypeArindam Dhar, June M Brindley, Cristi Stark, et al.Molecular Cancer Therapeutics|January 7, 2004
Inhibition of tumor growth by a novel approach: in situ allicin generation using targeted alliinase deliveryTalia Miron, Marina Mironchik, David Mirelman, et al.Molecular Cancer Therapeutics|November 18, 2003
Sensitization of breast cancer cells to radiation by trastuzumabKe Liang, Yang Lu, Weidong Jin, et al.Molecular Cancer Therapeutics|November 18, 2003
Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factorHiroji Uemura, Hitoshi Ishiguro, Noboru Nakaigawa, et al.Molecular Cancer Therapeutics|November 18, 2003
Voltage-gated sodium channel blockers as cytostatic inhibitors of the androgen-independent prostate cancer cell line PC-3James D Anderson, Todd P Hansen, Paul W Lenkowski, et al.Molecular Cancer Therapeutics|November 18, 2003
Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin's lymphoma B cell lines to paclitaxel-induced apoptosisAli R Jazirehi, Xiao-Hu Gan, Sven De Vos, et al.Molecular Cancer Therapeutics|November 18, 2003
Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance proteinTracy A Brooks, Hans Minderman, Kieran L O'Loughlin, et al.Molecular Cancer Therapeutics|November 18, 2003
Alpha-fetoprotein growth inhibitory peptides: potential leads for cancer therapeuticsGerald J Mizejewski, Robert MacCollPageof 601